反応式
Br[CH2:2][C:3]([NH:5][C:6]1[CH:11]=[C:10]([Cl:12])[N:9]=[C:8]([C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)[N:7]=1)=[O:4].[F:19][C:20]([F:37])([F:36])[C:21]1[CH:26]=[CH:25][C:24]([N:27]2[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]2)=[C:23]([N+:33]([O-:35])=[O:34])[CH:22]=1>C(#N)C>[Cl:12][C:10]1[N:9]=[C:8]([C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)[N:7]=[C:6]([NH:5][C:3](=[O:4])[CH2:2][N:30]2[CH2:31][CH2:32][N:27]([C:24]3[CH:25]=[CH:26][C:21]([C:20]([F:37])([F:19])[F:36])=[CH:22][C:23]=3[N+:33]([O-:35])=[O:34])[CH2:28][CH2:29]2)[CH:11]=1参加物
4
実験手順
2-Bromo-N-(6-chloro-2-phenylpyrimidin-4-yl)acetamide (100 mg) was dissolved in acetonitrile (5 ml) and (4-trifluromethyl-2-nitrophenyl)piperazine (253 mg) added. The solution was stirred overnight at room temperature. After this time the solvent was removed in vacuo. Purification by flash chromatography on silica gel eluting with a mixture of dichloromethane and methanol (98:2, then 93:7 v/v) afforded the title compound. m/z (ES+) 521 (MH)+
後処理
- customAfter this time the solvent was removed in vacuo
- customPurification by flash chromatography on silica gel eluting
- additionwith a mixture of dichloromethane and methanol (98:2
出典と根拠
- ORDレコード
- ord-a1e9d3f19e4d4db99ecc74a10676cf3e
- 出典データセット
- uspto-grants-2005_07
- 特許番号
- US06916804B2
関連ノート
読み込み中…